All Professor Qi Zeng (Senior Principal Scientist at A*STAR IMCB and founder of IISG) articles
-
NewsHow a PRL3-targeting cancer drug could help millions see again
Singapore researchers have found that cancer drug PRL3-zumab shows strong potential for treating wet age-related macular degeneration and diabetic retinopathy - two leading causes of blindness worldwide.